Skip to content

Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study)

Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00560677
Acronym
SAPPHIRE
Enrollment
400
Registered
2007-11-20
Start date
2007-03-31
Completion date
2023-12-31
Last updated
2021-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD, Schizophrenia

Keywords

Schizophrenia, PTSD, Cognition

Brief summary

We propose to establish a database characterizing the presence or absence of comorbid PTSD in veterans with schizophrenia or schizoaffective disorder (SAD) receiving services at the Durham VA Medical Center. In addition to the evaluation of PTSD symptoms in veterans with schizophrenia or SAD, this database will facilitate the investigation of a number of additional specific research questions relevant to veterans with psychotic disorders.

Detailed description

See brief summary

Interventions

None listed

Sponsors

Durham VA Medical Center
Lead SponsorFED

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 72 Years
Healthy volunteers
No

Inclusion criteria

1. 18-72 years of age, any ethnic group, either sex. 2. Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder. 3. Ability to fully participate in the informed consent process, or have a legal guardian able to participate in the informed consent process.

Exclusion criteria

1. Unstable current medical or neurological illness. 2. Significant suicidal or homicidal ideation. 3. Pregnant women or women who could be pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Brief Assessment of Cognition in Schizophrenia (BACS)Visit 1The Brief Assessment of Cognition in Schizophrenia (BACS) includes brief assessments of executive functions, verbal fluency, attention, verbal memory, working memory and motor speed. Z-scores are calculated from composite scores. Higher z-scores are indicative of better cognitive performance, lower z-scores are indicative of lower cognitive performance. Range of z-scores anticipated to be between -3 and 3.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026